Agriculture Biotechnology Market Size, Share, By Type (Molecular Diagnostics, Molecular Markers, Tissue Culture, Vaccines, and Genetic Engineering), By Application (Transgenic Crops and Synthetic Biology-Enabled Products), and By Region - Trends, Analysis and Forecast till 2034

Report Code: PMI291319 | Publish Date: March 2024 | No. of Pages: 186

Global Agriculture Biotechnology Market Market Trends

Agriculture biotechnology is critical in addressing these challenges because it provides innovative solutions for increasing crop productivity, improving food security, and meeting the needs of a growing population in a sustainable manner. The growing global population is a major factor influencing the agriculture biotechnology market. As the global population grows, so does the demand for food, feed, fiber, and other agricultural products.

Biotechnology enables the development of crops with improved nutritional properties. For example, bio fortification can be used to boost the levels of essential vitamins, minerals, and other nutrients in crops, making them more nutritious for consumers.  Biotech crops can be engineered to be naturally resistant to pests and diseases, reducing the need for chemical pesticides and herbicides. This results in crops that are less likely to contain harmful residues, thereby improving food safety. As consumers become more health-conscious and aware of the consequences of their food choices, agriculture biotechnology has the potential to meet their demand for safer and more nutritious foods. Addressing public concerns, maintaining transparency, and adhering to regulatory standards are all critical for establishing and maintaining consumer trust in biotech-derived products.

Unexpected ecological risks are one of the major impediments to the agricultural biotechnology market. Uncertainty and the possibility of unintended consequences are inherent in any new technology or innovation. Unexpected ecological risks in agriculture biotechnology refer to potential negative environmental consequences that were not anticipated during the development and deployment of biotech products.